
Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
2026-07-31BGLC3Initial Statement of Beneficial Ownership of Securities
This filing reports the initial statement of beneficial ownership of securities for Tan Lee Su-Leng, CEO and Director of BioNexus Gene Lab Corp. The report, filed on August 15, 2023, indicates no securities owned following the transaction. The owner resides in Kuala Lumpur, Malaysia....
Nano CapSpecialty Chemicals
2026-07-31VTGN3Power of Attorney FilingMEDIUM
This filing details a Power of Attorney granted by Douglas J. Williamson, a director of Vistagen Therapeutics, Inc., to Nick B. Tressler and Shawn K. Singh. The attorneys-in-fact are authorized to act on Mr. Williamson's behalf regarding SEC filings, including preparing, executing, and submitting forms such as 3, 4, 5,...
Nano CapBiotechnology
2026-07-31GLRE3GREENLIGHT CAPITAL RE, LTD. - Form 3 Filing
This filing details a Form 3, Initial Statement of Beneficial Ownership, for GREENLIGHT CAPITAL RE, LTD. (GLRE). The reporting owner, Ariel Warszawski, who is a director at the company, reported 0 shares owned following the transaction. The ownership is direct. The filing date was July 31, 2026, with the period of repo...
Small CapInsurance - Reinsurance
2026-07-31PAY3Power of Attorney for Gregory Hyde WilliamsMEDIUM
This filing details a Limited Power of Attorney granted by Gregory Hyde Williams, a director at Paymentus Holdings, Inc. (PAY), to Thomas C. Barnds. This appointment authorizes Barnds to act on Williams' behalf regarding securities transactions and filings with the SEC. This includes executing necessary forms such as S...
Mid CapSoftware - Infrastructure
2026-07-31Vistagen Therapeutics, Inc.3Power of Attorney FilingDuplicateMEDIUM
This filing details a Power of Attorney granted by Douglas J. Williamson, a director of Vistagen Therapeutics, Inc., to Nick B. Tressler and Shawn K. Singh. The attorneys-in-fact are authorized to act on Mr. Williamson's behalf regarding SEC filings, including preparing, executing, and submitting forms such as 3, 4, 5,...
Nano CapBiotechnology
2026-07-31GEN3Power of Attorney for Travis WitteveenMEDIUM
This filing is an Exhibit 24, a Power of Attorney, for Travis Witteveen, Head of Products and Portfolio at Gen Digital Inc. The document, dated June 15, 2026, authorizes Bryan Ko, Whitney Clark, and Kathryn White to act as attorneys-in-fact. They are empowered to execute, deliver, and file Forms 3, 4, and 5, including ...
Large CapSoftware - Infrastructure
2026-07-31TOP3Form 3 Filing for TOP Financial Group LtdHIGH
This filing details insider ownership for TOP Financial Group Ltd. Yang Junli, identified as a 10% owner, officer, and director, reports holdings through two entities: Zhong Yang Holdings (BVI) Limited and QUANTUM LEAP LIMITED. Yang Junli holds 10,000,000 Class B Ordinary Shares directly. Indirectly, through Zhong Yang...
Small CapCapital Markets
Sponsored
2026-07-31BGLC3Initial Statement of Beneficial Ownership
This filing reports that Yap Chee Keong, a director at BioNexus Gene Lab Corp, has initially acquired 0 shares of common stock. The ownership is direct, and the report was filed on March 7, 2022....
Nano CapSpecialty Chemicals
2026-07-31TOP3Insider Filing for TOP Financial Group Ltd
This filing reports insider ownership information for TOP Financial Group Ltd. The reporting owner, Yuen Ka Fai, who is a Director & CEO of the company, has reported no securities owned as of March 18, 2026. The signature date was July 31, 2026. This is a Form 3 filing, which is an initial statement of beneficial owner...
Small CapCapital Markets
Sponsored
Sponsored